Wednesday - May 7, 2025

LOGIN  |  REGISTER

Recent Insider Transactions - Inhibikase Therapeutics (NASDAQ: IKT)

Follow NASDAQ:IKT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ IKT Inhibikase Therapeutics
McIntyre David / officer: Chief Financial Officer
04/14/2025
Buy
$2.00
1.78M
$3.551M
1.78M

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous